Pelargonium (EPs 7630)
South African geranium root extract; the Cochrane review found benefit in acute bronchitis for the liquid preparation, not tablets.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- EPs 7630 liquid: 30 drops three times daily for 7 days
- Time to effect
- Symptom reduction often within 4–7 days
- Safety
- Has documented cautions
Evidence ratings summarise published research on Pelargonium (EPs 7630) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Pelargonium (EPs 7630)
Interactions
Taking any medication?
Check Pelargonium (EPs 7630) against it.
Why
Pelargonium sidoides root (extract EPs 7630) has been studied in acute bronchitis. The Cochrane review of trials in adults and children found the liquid preparation showed benefit for most outcomes, but tablets did not; the evidence was low quality and results were not pooled. NICE rated the evidence very low to low quality and made no positive recommendation.
How it works
Antiviral activity against respiratory viruses (rhinovirus, coronavirus, influenza, RSV), blocks viral attachment and replication in vitro. Stimulates ciliary beat frequency in respiratory epithelium, enhances macrophage phagocytosis, and induces interferon-β.
Expected onset · Symptom reduction often within 4–7 days
How to take
Dosage
EPs 7630 liquid: 30 drops three times daily for 7 days (adults). Tablets: 20 mg three times daily. Children's doses are weight-banded and product-specific.
Timing
Three times daily, away from meals if possible
On the label
The trials used the extract EPs 7630; generic Pelargonium products vary widely and may not match it.
Studied in
Adults and children (over 6 years) with acute uncomplicated bronchitis.
Safety
Evidence
Timmer 2013 Cochrane review (3 trials in 746 adults and 3 in 819 children with acute bronchitis; low-quality evidence): the liquid Pelargonium sidoides preparation showed benefit for most outcomes, but tablets did not, and results were not pooled. NICE (2019) made no positive recommendation, rating the evidence very low to low quality.
GRADE certainty: Low — reported by Cochrane 2013 (low quality of evidence)
Questions people ask
Does Pelargonium (EPs 7630) work?
Timmer 2013 Cochrane review (3 trials in 746 adults and 3 in 819 children with acute bronchitis; low-quality evidence): the liquid Pelargonium sidoides preparation showed benefit for most outcomes, but tablets did not, and results were not pooled. NICE (2019) made no positive recommendation, rating the evidence very low to low quality. Certainty of the evidence: Low, reported by Cochrane 2013 (low quality of evidence).
How is Pelargonium (EPs 7630) taken?
EPs 7630 liquid: 30 drops three times daily for 7 days (adults). Tablets: 20 mg three times daily. Children's doses are weight-banded and product-specific. Timing: Three times daily, away from meals if possible. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Rare hepatotoxicity reports. Stop and seek medical advice for any unexplained jaundice, nausea, or fatigue. Avoid in active liver disease. Bleeding risk. Caution with anticoagulants and antiplatelets, stop 2 weeks before surgery. Pregnancy data limited. Allergic skin reactions possible. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Timmer et al., Cochrane Database Syst Rev 2013, Pelargonium sidoides extract for acute respiratory tract infections; NICE guideline (2019): Cough (acute): antimicrobial prescribing – NG120 (Summary of the Evidence).
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.